-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
(1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(tritylamino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol is an organic compound that is commonly used in the pharmaceutical and chemical industries.
This compound is classified as an intermediate or a building block for the synthesis of other pharmaceutical products.
Upstream and downstream products refer to the compounds that are used as raw materials in the synthesis of the intermediate, (1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(tritylamino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol, and the final products that are produced using this intermediate.
Upstream products are the compounds that are used as raw materials in the synthesis of (1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(tritylamino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol.
These raw materials are typically obtained from natural sources or synthesized in the laboratory using chemical reactions.
In the case of (1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(tritylamino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol, the upstream products are the starting materials used in the synthesis of this compound.
The upstream products for (1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(tritylamino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol typically include the starting materials for each individual synthesis step.
For example, the synthesis of (1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(tritylamino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol may involve several synthesis steps, each requiring a different set of starting materials.
In this case, the upstream products include the starting materials used in each of these synthesis steps.
Downstream products are the final products that are produced using (1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(tritylamino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol as an intermediate.
In the case of (1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(tritylamino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol, the downstream products include the final pharmaceutical products that are produced using this compound as an intermediate in the synthesis process.
The downstream products for (1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(tritylamino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol can vary depending on the intended use of the compound.
For example, this compound may be used as an intermediate in the synthesis of a new pharmaceutical drug, in which case the downstream product would be the final pharmaceutical drug that is produced using this compound as an intermediate.
Alternatively, (1
